These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2565749)

  • 81. Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.
    Leone P; Di Chiara G
    Eur J Pharmacol; 1987 Mar; 135(2):251-4. PubMed ID: 3556198
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Unilateral, intranigral infusions of amphetamine produce differential, bilateral changes in unit activity and extracellular levels of ascorbate in the neostriatum of the rat.
    Wilson RL; Kamata K; Wightman RM; Rebec GV
    Brain Res; 1986 Oct; 384(2):342-7. PubMed ID: 3779385
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism.
    White LK; Carpenter M; Block M; Basse-Tomusk A; Gardiner TW; Rebec GV
    Psychopharmacology (Berl); 1988; 94(2):284-7. PubMed ID: 2832869
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mesocortical dopaminergic neurons. 2. Electrophysiological consequences of terminal autoreceptor activation.
    Gariano RF; Sawyer SF; Tepper JM; Young SJ; Groves PM
    Brain Res Bull; 1989 Mar; 22(3):517-23. PubMed ID: 2713724
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-cortico-neostriatal loop.
    Pierce RC; Clemens AJ; Grabner CP; Rebec GV
    J Neurochem; 1994 Oct; 63(4):1499-507. PubMed ID: 7931303
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?
    Baptista T; Parada M; Hernandez L
    Pharmacol Biochem Behav; 1987 Jul; 27(3):399-405. PubMed ID: 2889218
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission.
    Rebec GV; Pierce RC
    Prog Neurobiol; 1994 Aug; 43(6):537-65. PubMed ID: 7816935
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioural screen for antipsychotic activity.
    Roberts DC; Vickers G
    Psychopharmacology (Berl); 1984; 82(1-2):135-9. PubMed ID: 6141584
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Changes in catalepsy and receptor sensitivity following chronic neuroleptic treatment.
    Allikmets LH; Zarkovsky AM; Nurk AM
    Eur J Pharmacol; 1981 Oct; 75(2-3):145-7. PubMed ID: 6119215
    [No Abstract]   [Full Text] [Related]  

  • 90. Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs.
    Bardo MT; Neisewander JL; Pierce RC
    Pharmacol Biochem Behav; 1989 Mar; 32(3):683-9. PubMed ID: 2544904
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Levels of insulin in the brains of rats modified by chronic administration of amphetamine, haloperidol and sulpiride.
    Manzanares J; Cantón R; Grande C; Benedí J; Zaragozá F
    Neuropharmacology; 1988 Nov; 27(11):1141-4. PubMed ID: 3060757
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dopamine D1-receptor stimulation reduces neostriatal cholecystokinin release.
    Meyer DK; Holland A; Conzelmann U
    Eur J Pharmacol; 1984 Sep; 104(3-4):387-8. PubMed ID: 6389158
    [No Abstract]   [Full Text] [Related]  

  • 93. Ciclindole and flucindole: novel tetrahydrocarbazolamine neuroleptics.
    Wood PL; McQuade PS
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):773-7. PubMed ID: 6152347
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Intracerebral injection of ascorbate oxidase - effect on in vivo electrochemical recordings.
    Brazell MP; Marsden CA
    Brain Res; 1982 Oct; 249(1):167-72. PubMed ID: 7139292
    [No Abstract]   [Full Text] [Related]  

  • 95. Attenuation of D-1 antagonist-induced D-1 receptor upregulation by concomitant D-2 receptor blockade.
    Parashos SA; Barone P; Tucci I; Chase TN
    Life Sci; 1987 Nov; 41(20):2279-84. PubMed ID: 3316889
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.
    Bøgesø KP
    J Med Chem; 1983 Jul; 26(7):935-47. PubMed ID: 6134833
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat.
    O'Neill RD; Fillenz M; Sundstrom L; Rawlins JN
    Neurosci Lett; 1984 Dec; 52(3):227-33. PubMed ID: 6521967
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The monitoring of ascorbate and monoamine transmitter metabolites in the striatum of unanaesthetised rats using microprocessor-based voltammetry.
    O'Neill RD; Fillenz M; Albery WJ; Goddard NJ
    Neuroscience; 1983 May; 9(1):87-93. PubMed ID: 6192357
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat.
    Wilson RL; Wightman RM
    Brain Res; 1985 Jul; 339(2):219-26. PubMed ID: 4027622
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Autoradiographic localization of dopamine D1 binding sites in areas receiving striatal input.
    Graham WC; Crossman AR
    Eur J Pharmacol; 1987 Oct; 142(3):479-81. PubMed ID: 2892688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.